US Patent Issued to Regeneron Pharmaceuticals on June 2 for "Lyophilized formulations of AAV drug products" (New York, New Jersey Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,871, issued on June 2, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Lyophilized formulations of AAV drug products" was invented by Dingjiang Liu (Pleasantville, N.Y.), Li Zhi (Tarrytown, N.Y.), Yao Chen (Whitestone, N.Y.), Kuan-Yu Lai (Livingston, N.J.), Jonathan Wert (Yorktown Heights, N.Y.) and Xiaoyan Wang (White Plains, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides stable lyophilized pharmaceutical compositions comprising recombinant adeno-associated virus (rAAV) particles. In certain embodiments, the compositions contain, in addition to the rAAV particles, a buffer, one or more salts, a...